1. Home
  2. GDTC vs CYN Comparison

GDTC vs CYN Comparison

Compare GDTC & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • CYN
  • Stock Information
  • Founded
  • GDTC 2018
  • CYN 2013
  • Country
  • GDTC Singapore
  • CYN United States
  • Employees
  • GDTC N/A
  • CYN N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • CYN EDP Services
  • Sector
  • GDTC Health Care
  • CYN Technology
  • Exchange
  • GDTC Nasdaq
  • CYN Nasdaq
  • Market Cap
  • GDTC 28.0M
  • CYN 28.0M
  • IPO Year
  • GDTC 2023
  • CYN 2021
  • Fundamental
  • Price
  • GDTC $1.86
  • CYN $9.33
  • Analyst Decision
  • GDTC Buy
  • CYN
  • Analyst Count
  • GDTC 1
  • CYN 0
  • Target Price
  • GDTC $5.00
  • CYN N/A
  • AVG Volume (30 Days)
  • GDTC 10.3K
  • CYN 12.9M
  • Earning Date
  • GDTC 01-01-0001
  • CYN 08-06-2025
  • Dividend Yield
  • GDTC N/A
  • CYN N/A
  • EPS Growth
  • GDTC N/A
  • CYN N/A
  • EPS
  • GDTC N/A
  • CYN N/A
  • Revenue
  • GDTC $368,838.00
  • CYN $409,777.00
  • Revenue This Year
  • GDTC $5.37
  • CYN $1,162.03
  • Revenue Next Year
  • GDTC N/A
  • CYN $427.83
  • P/E Ratio
  • GDTC N/A
  • CYN N/A
  • Revenue Growth
  • GDTC N/A
  • CYN N/A
  • 52 Week Low
  • GDTC $1.20
  • CYN $3.62
  • 52 Week High
  • GDTC $4.05
  • CYN $1,312.50
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 41.07
  • CYN 52.05
  • Support Level
  • GDTC $1.96
  • CYN $8.20
  • Resistance Level
  • GDTC $2.26
  • CYN $9.72
  • Average True Range (ATR)
  • GDTC 0.10
  • CYN 1.28
  • MACD
  • GDTC -0.02
  • CYN -0.45
  • Stochastic Oscillator
  • GDTC 17.95
  • CYN 11.56

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About CYN Cyngn Inc.

Cyngn Inc is an industrial autonomous vehicle technology company. Its flagship innovation is DriveMod, an autonomous driving solution that can be flexibly deployed on multiple vehicle types manufactured by Original Equipment Manufacturers in various environments.

Share on Social Networks: